
Stem Cell Therapeutics (SCT) Profile last edited on: 00/00/00
NO Business Identifier is currently available for this company. Year Founded
----Last Involved Year
N/AKey People / Management
Location Information
,
N/A |
N/A |
Public Profile
SCT and StemCells in cross-licensing deal
Deal Date: Aug-01-2006 / Deal # 200620565
Executive Summary
StemCells (cell therapeutics for CNS, liver, and pancreatic diseases) has licensed its neural stem cells to Stem Cell Therapeutics (SCT), which develops pharmaceutical treatments that stimulate endogenous stem cell growth. SCT is simultaneously giving StemCells access to its IP for use in drug discovery, screening, testing, and therapeutic use of cellular compositions.
Extent of SBIR involvement
Synopsis: Techseeker Business Condition
Headquartered
Employment
N/ARevenue
N/APublic/Private
Privately HeldStock Info
----Received SBIR $$
NoTechseeker firm in the news
There are no news available.